NYSE:PAY charts & data provided by TradingView

Latest Insights on PAY

buy stocks omicron dip Buy the Omicron Dip! (But Choose Wisely) December 3, 2021 by Ted Bauman Big Picture. Big Profits., Investing Markets went haywire this week (and last) in response to a double whammy: Omicron’s appearance on the COVID stage and a suddenly hawkish Fed. Stocks dropped across the board … but some dropped more than others. That confirms what I’ve been saying for most of 2021: The market increasingly prefers quality and consistent earnings growth […]
Boeing 737 Max cleared in China for takeoff dog meme Boeing Bites Back; Whistling Tesla; Dolla Dolla General December 2, 2021 by Joseph Hargett Great Stuff A Flight Of Fancy On A Windswept Field Into the distance, a ribbon of sell-offs … stretched to the point of no turning back. Great Ones, I can’t keep my eyes from the circling sky today. Tongue-tied and twisted. Just an earthbound misfit, I … by golly, by gosh, I think Boeing’s (NYSE: ) learning […]
Jurassic Park Nobody Cares Omicron Variant Meme On DoorDashers, On Box’ers, On Chipmakers … C’mon, Becto! December 1, 2021 by Joseph Hargett Great Stuff A Little Dash’ll Do Ya? It’s been, what … less than a week since COVID-19 Omicron debuted, and I’m already tired of it. And I’m sure you’re tired of hearing about Omicron as well, Great Ones. Wall Street is also tired of it, apparently, as stocks attempted to push sharply higher today. But, as resilient […]
inflation How to Beat the Inflation Tapeworm December 1, 2021 by Charles Mizrahi Investment Opportunities, Real Talk, Stocks, U.S. Economy (4-minute read) Soaring demand and worker shortages are making the supply chain crisis worse. It’s the perfect storm for higher prices. But here’s how you can combat inflation today…
omicron Adagio Therapeutics A Stock-Picking Mutation to Beat the Omicron Threat November 30, 2021 by Ted Bauman Big Picture. Big Profits., Global Economy, News This is a company that has never made a profit. In fact, it’s never made any money at all. On top of that, analysts expect its per-share losses to double by the end of 2022. Assuming Adagio manages to generate some revenues next year — the market consensus is a minuscule $151 million — it’s already trading at almost 20 times those sales. Why? Because COVID is here to stay … and the search for a response is moving into new areas … quickly.

Newsletter Sign Up

Sponsored

CS Care Video

MEET OUR EXPERTS

WHAT READERS ARE SAYING..

“Loving this. Should have started a long time ago.”

- Jay

"You told me to ignore the noise on Wall Street. And thanks to you, I started towards the end of 2016 with $200,000 in my account and I recently put in an extra $100,000. [As of February 2019] My account is worth $500,788! I would’ve missed out if I followed conventional wisdom."

- Helen C.

“My portfolio has grown from 275k to almost 900k with only investments made with Banyan Hill.”

- David G. (Member since 2018)

Share This